Greener synthesis of lignin nanoparticles and their applications
The remarkable absorption capacity, biodegradability and non-toxicity of lignin
nanoparticles enable them to be appropriate vehicles for drug molecules and inorganic …
nanoparticles enable them to be appropriate vehicles for drug molecules and inorganic …
Biological activities and emerging roles of lignin and lignin-based products─ A review
Bioactive substances, displaying excellent biocompatibility, chemical stability, and
processability, could be extensively applied in biomedicine and tissue engineering. In recent …
processability, could be extensively applied in biomedicine and tissue engineering. In recent …
中国艾滋病防治面临新形势与新挑战
吴尊友 - 中国公共卫生, 2011 - zgggws.com
今年是世界艾滋病流行以来的第30 个年头, 全球艾滋病流行与防治形势都发生了巨大的变化.
自上世纪九十年代中期高效联合抗逆转录病毒治疗(highly active antiretroviral therapy …
自上世纪九十年代中期高效联合抗逆转录病毒治疗(highly active antiretroviral therapy …
Efficacy, safety, and effect on sexual behaviour of on-demand pre-exposure prophylaxis for HIV in men who have sex with men: an observational cohort study
Background Data for on-demand pre-exposure prophylaxis (PrEP) are scarce. We
implemented a cohort study to assess its efficacy, safety, and effect on sexual behaviour …
implemented a cohort study to assess its efficacy, safety, and effect on sexual behaviour …
Use of a vaginal ring containing dapivirine for HIV-1 prevention in women
Background Antiretroviral medications that are used as prophylaxis can prevent acquisition
of human immunodeficiency virus type 1 (HIV-1) infection. However, in clinical trials among …
of human immunodeficiency virus type 1 (HIV-1) infection. However, in clinical trials among …
Tenofovir-based preexposure prophylaxis for HIV infection among African women
Background Reproductive-age women need effective interventions to prevent the
acquisition of human immunodeficiency virus type 1 (HIV-1) infection. Methods We …
acquisition of human immunodeficiency virus type 1 (HIV-1) infection. Methods We …
HIV infection: epidemiology, pathogenesis, treatment, and prevention
G Maartens, C Celum, SR Lewin - The Lancet, 2014 - thelancet.com
HIV prevalence is increasing worldwide because people on antiretroviral therapy are living
longer, although new infections decreased from 3· 3 million in 2002, to 2· 3 million in 2012 …
longer, although new infections decreased from 3· 3 million in 2002, to 2· 3 million in 2012 …
Vaginal bacteria modify HIV tenofovir microbicide efficacy in African women
Antiretroviral-based strategies for HIV prevention have shown inconsistent results in women.
We investigated whether vaginal microbiota modulated tenofovir gel microbicide efficacy in …
We investigated whether vaginal microbiota modulated tenofovir gel microbicide efficacy in …
Viral infections, the microbiome, and probiotics
A Harper, V Vijayakumar, AC Ouwehand… - Frontiers in Cellular …, 2021 - frontiersin.org
Viral infections continue to cause considerable morbidity and mortality around the world.
Recent rises in these infections are likely due to complex and multifactorial external drivers …
Recent rises in these infections are likely due to complex and multifactorial external drivers …
A systematic review of interventions to reduce HIV‐related stigma and discrimination from 2002 to 2013: how far have we come?
AL Stangl, JK Lloyd, LM Brady… - Journal of the …, 2013 - Wiley Online Library
Introduction HIV‐related stigma and discrimination continue to hamper efforts to prevent new
infections and engage people in HIV treatment, care and support programmes. The …
infections and engage people in HIV treatment, care and support programmes. The …